129 related articles for article (PubMed ID: 10836991)
1. Inhibition of type I and III IP(3)Rs by TGF-beta is associated with impaired calcium release in mesangial cells.
Sharma K; Mc Gowan TA; Wang L; Madesh M; Kaspar V; Szalai G; Thomas AP; Hajnóczky G
Am J Physiol Renal Physiol; 2000 Jun; 278(6):F1022-9. PubMed ID: 10836991
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta-induced Ca(2+) influx involves the type III IP(3) receptor and regulates actin cytoskeleton.
McGowan TA; Madesh M; Zhu Y; Wang L; Russo M; Deelman L; Henning R; Joseph S; Hajnoczky G; Sharma K
Am J Physiol Renal Physiol; 2002 May; 282(5):F910-20. PubMed ID: 11934702
[TBL] [Abstract][Full Text] [Related]
3. Functional properties of recombinant type I and type III inositol 1, 4,5-trisphosphate receptor isoforms expressed in COS-7 cells.
Boehning D; Joseph SK
J Biol Chem; 2000 Jul; 275(28):21492-9. PubMed ID: 10764774
[TBL] [Abstract][Full Text] [Related]
4. Functional properties of Drosophila inositol trisphosphate receptors.
Swatton JE; Morris SA; Wissing F; Taylor CW
Biochem J; 2001 Oct; 359(Pt 2):435-41. PubMed ID: 11583592
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 inhibits type I inositol 1,4,5-trisphosphate receptor expression and enhances its phosphorylation in mesangial cells.
Sharma K; Wang L; Zhu Y; Bokkala S; Joseph SK
J Biol Chem; 1997 Jun; 272(23):14617-23. PubMed ID: 9169422
[TBL] [Abstract][Full Text] [Related]
6. Crucial role of type 1, but not type 3, inositol 1,4,5-trisphosphate (IP(3)) receptors in IP(3)-induced Ca(2+) release, capacitative Ca(2+) entry, and proliferation of A7r5 vascular smooth muscle cells.
Wang Y; Chen J; Wang Y; Taylor CW; Hirata Y; Hagiwara H; Mikoshiba K; Toyo-oka T; Omata M; Sakaki Y
Circ Res; 2001 Feb; 88(2):202-9. PubMed ID: 11157673
[TBL] [Abstract][Full Text] [Related]
7. IP(3)-mediated Ca(2+) signals in human neuroblastoma SH-SY5Y cells with exogenous overexpression of type 3 IP(3) receptor.
Van Acker K; Nadif Kasri N; De Smet P; Parys JB; De Smedt H; Missiaen L; Callewaert G
Cell Calcium; 2002 Aug; 32(2):71-81. PubMed ID: 12161107
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation of inositol 1,4,5-trisphosphate receptor type 1 and type 3 by ATP.
Maes K; Missiaen L; De Smet P; Vanlingen S; Callewaert G; Parys JB; De Smedt H
Cell Calcium; 2000 May; 27(5):257-67. PubMed ID: 10859592
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor activates store-operated Ca2+ channels through an inositol 1,4,5-trisphosphate-independent pathway in human glomerular mesangial cells.
Li WP; Tsiokas L; Sansom SC; Ma R
J Biol Chem; 2004 Feb; 279(6):4570-7. PubMed ID: 14612458
[TBL] [Abstract][Full Text] [Related]
10. Type 3 inositol trisphosphate receptors in RINm5F cells are biphasically regulated by cytosolic Ca2+ and mediate quantal Ca2+ mobilization.
Swatton JE; Morris SA; Cardy TJ; Taylor CW
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):55-60. PubMed ID: 10548533
[TBL] [Abstract][Full Text] [Related]
11. Fertilization and inositol 1,4,5-trisphosphate (IP3)-induced calcium release in type-1 inositol 1,4,5-trisphosphate receptor down-regulated bovine eggs.
Malcuit C; Knott JG; He C; Wainwright T; Parys JB; Robl JM; Fissore RA
Biol Reprod; 2005 Jul; 73(1):2-13. PubMed ID: 15744020
[TBL] [Abstract][Full Text] [Related]
12. Nuclear inositol 1,4,5-trisphosphate receptors regulate local Ca2+ transients and modulate cAMP response element binding protein phosphorylation.
Cárdenas C; Liberona JL; Molgó J; Colasante C; Mignery GA; Jaimovich E
J Cell Sci; 2005 Jul; 118(Pt 14):3131-40. PubMed ID: 16014380
[TBL] [Abstract][Full Text] [Related]
13. Novel biochemical and functional insights into nuclear Ca(2+) transport through IP(3)Rs and RyRs in osteoblasts.
Adebanjo OA; Biswas G; Moonga BS; Anandatheerthavarada HK; Sun L; Bevis PJ; Sodam BR; Lai FA; Avadhani NG; Zaidi M
Am J Physiol Renal Physiol; 2000 May; 278(5):F784-91. PubMed ID: 10807590
[TBL] [Abstract][Full Text] [Related]
14. Inositol-1,4,5-trisphosphate-dependent Ca(2+) signalling in cat atrial excitation-contraction coupling and arrhythmias.
Zima AV; Blatter LA
J Physiol; 2004 Mar; 555(Pt 3):607-15. PubMed ID: 14754996
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of inositol 1,4,5-trisphosphate receptor in cells stably expressing the constitutively active angiotensin II N111G-AT(1) receptor.
Auger-Messier M; Arguin G; Chaloux B; Leduc R; Escher E; Guillemette G
Mol Endocrinol; 2004 Dec; 18(12):2967-80. PubMed ID: 15331757
[TBL] [Abstract][Full Text] [Related]
16. Emergence of a functional coupling between inositol-1,4,5-trisphosphate receptors and calcium channels in developing neocortical neurons.
Yamamoto K; Nakano M; Hashimoto K; Shimohama S; Kato N
Neuroscience; 2002; 109(4):677-85. PubMed ID: 11927150
[TBL] [Abstract][Full Text] [Related]
17. Regulation of inositol 1,4,5-trisphosphate receptors by transforming growth factor-beta: implications for vascular dysfunction in diabetes.
McGowan TA; Sharma K
Kidney Int Suppl; 2000 Sep; 77():S99-103. PubMed ID: 10997698
[TBL] [Abstract][Full Text] [Related]
18. Xestospongin C, a novel blocker of IP3 receptor, attenuates the increase in cytosolic calcium level and degranulation that is induced by antigen in RBL-2H3 mast cells.
Oka T; Sato K; Hori M; Ozaki H; Karaki H
Br J Pharmacol; 2002 Apr; 135(8):1959-66. PubMed ID: 11959799
[TBL] [Abstract][Full Text] [Related]
19. Microtubule-dependent redistribution of the type-1 inositol 1,4,5-trisphosphate receptor in A7r5 smooth muscle cells.
Vermassen E; Van Acker K; Annaert WG; Himpens B; Callewaert G; Missiaen L; De Smedt H; Parys JB
J Cell Sci; 2003 Apr; 116(Pt 7):1269-77. PubMed ID: 12615969
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C phosphorylates the inositol 1,4,5-trisphosphate receptor type 2 and decreases the mobilization of Ca2+in pancreatoma AR4-2J cells.
Arguin G; Regimbald-Dumas Y; Fregeau MO; Caron AZ; Guillemette G
J Endocrinol; 2007 Mar; 192(3):659-68. PubMed ID: 17332533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
